Cargando…

Amelioration of AOM/DSS-Induced Murine Colitis-Associated Cancer by Evodiamine Intervention is Primarily Associated with Gut Microbiota-Metabolism-Inflammatory Signaling Axis

Evodiamine (EVO), an indole alkaloid derived from Rutaceae plants Evodia rutaecarpa (Juss.) Benth.、Evodia rutaecarpa (Juss.) Benth. Var. bodinieri (Dode) Huang or Evodia rutaecarpa (Juss.) Benth. Var. officinalis (Dode) Huang, has anti-inflammatory and anti-tumor activities. Our previous study found...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mengxia, Zhou, Biqiang, Cong, Weihong, Zhang, Miao, Li, Ziwen, Li, Yan, Liang, Shaoyu, Chen, Keji, Yang, Depo, Wu, Zhengzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740177/
https://www.ncbi.nlm.nih.gov/pubmed/35002731
http://dx.doi.org/10.3389/fphar.2021.797605
_version_ 1784629256542748672
author Wang, Mengxia
Zhou, Biqiang
Cong, Weihong
Zhang, Miao
Li, Ziwen
Li, Yan
Liang, Shaoyu
Chen, Keji
Yang, Depo
Wu, Zhengzhi
author_facet Wang, Mengxia
Zhou, Biqiang
Cong, Weihong
Zhang, Miao
Li, Ziwen
Li, Yan
Liang, Shaoyu
Chen, Keji
Yang, Depo
Wu, Zhengzhi
author_sort Wang, Mengxia
collection PubMed
description Evodiamine (EVO), an indole alkaloid derived from Rutaceae plants Evodia rutaecarpa (Juss.) Benth.、Evodia rutaecarpa (Juss.) Benth. Var. bodinieri (Dode) Huang or Evodia rutaecarpa (Juss.) Benth. Var. officinalis (Dode) Huang, has anti-inflammatory and anti-tumor activities. Our previous study found that EVO attenuates colitis by regulating gut microbiota and metabolites. However, little is known about its effect on colitis-associated cancer (CAC). In this study, the protective effects of EVO on azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced colitis and tumor mice were observed, and the underlying potential mechanism was clarified. The results suggested that EVO ameliorated AOM/DSS-induced colitis by inhibiting the intestinal inflammation and improving mucosal barrier function. And EVO significantly reduced the number and size of AOM/DSS-induced colorectal tumors along with promoted apoptosis and inhibited proliferation of epithelial cell. Moreover, EVO promoted the enrichment of SCFAs-producing bacteria and reduced the levels of the pro-inflammatory bacteria, which contributes to the changes of microbiota metabolism, especially tryptophan metabolism. Furthermore, inflammatory response (like Wnt signaling pathway、Hippo signaling pathway and IL-17 signaling pathway) were effectively alleviated by EVO. Our study demonstrated that the protective therapeutic action of EVO on CAC is to inhibit the development of intestinal inflammation-cancer by regulating gut microbiota metabolites and signaling pathways of colon intestinal epithelial, which may represent a novel agent for colon cancer prevention via manipulation of gut microbiota.
format Online
Article
Text
id pubmed-8740177
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87401772022-01-08 Amelioration of AOM/DSS-Induced Murine Colitis-Associated Cancer by Evodiamine Intervention is Primarily Associated with Gut Microbiota-Metabolism-Inflammatory Signaling Axis Wang, Mengxia Zhou, Biqiang Cong, Weihong Zhang, Miao Li, Ziwen Li, Yan Liang, Shaoyu Chen, Keji Yang, Depo Wu, Zhengzhi Front Pharmacol Pharmacology Evodiamine (EVO), an indole alkaloid derived from Rutaceae plants Evodia rutaecarpa (Juss.) Benth.、Evodia rutaecarpa (Juss.) Benth. Var. bodinieri (Dode) Huang or Evodia rutaecarpa (Juss.) Benth. Var. officinalis (Dode) Huang, has anti-inflammatory and anti-tumor activities. Our previous study found that EVO attenuates colitis by regulating gut microbiota and metabolites. However, little is known about its effect on colitis-associated cancer (CAC). In this study, the protective effects of EVO on azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced colitis and tumor mice were observed, and the underlying potential mechanism was clarified. The results suggested that EVO ameliorated AOM/DSS-induced colitis by inhibiting the intestinal inflammation and improving mucosal barrier function. And EVO significantly reduced the number and size of AOM/DSS-induced colorectal tumors along with promoted apoptosis and inhibited proliferation of epithelial cell. Moreover, EVO promoted the enrichment of SCFAs-producing bacteria and reduced the levels of the pro-inflammatory bacteria, which contributes to the changes of microbiota metabolism, especially tryptophan metabolism. Furthermore, inflammatory response (like Wnt signaling pathway、Hippo signaling pathway and IL-17 signaling pathway) were effectively alleviated by EVO. Our study demonstrated that the protective therapeutic action of EVO on CAC is to inhibit the development of intestinal inflammation-cancer by regulating gut microbiota metabolites and signaling pathways of colon intestinal epithelial, which may represent a novel agent for colon cancer prevention via manipulation of gut microbiota. Frontiers Media S.A. 2021-12-24 /pmc/articles/PMC8740177/ /pubmed/35002731 http://dx.doi.org/10.3389/fphar.2021.797605 Text en Copyright © 2021 Wang, Zhou, Cong, Zhang, Li, Li, Liang, Chen, Yang and Wu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Mengxia
Zhou, Biqiang
Cong, Weihong
Zhang, Miao
Li, Ziwen
Li, Yan
Liang, Shaoyu
Chen, Keji
Yang, Depo
Wu, Zhengzhi
Amelioration of AOM/DSS-Induced Murine Colitis-Associated Cancer by Evodiamine Intervention is Primarily Associated with Gut Microbiota-Metabolism-Inflammatory Signaling Axis
title Amelioration of AOM/DSS-Induced Murine Colitis-Associated Cancer by Evodiamine Intervention is Primarily Associated with Gut Microbiota-Metabolism-Inflammatory Signaling Axis
title_full Amelioration of AOM/DSS-Induced Murine Colitis-Associated Cancer by Evodiamine Intervention is Primarily Associated with Gut Microbiota-Metabolism-Inflammatory Signaling Axis
title_fullStr Amelioration of AOM/DSS-Induced Murine Colitis-Associated Cancer by Evodiamine Intervention is Primarily Associated with Gut Microbiota-Metabolism-Inflammatory Signaling Axis
title_full_unstemmed Amelioration of AOM/DSS-Induced Murine Colitis-Associated Cancer by Evodiamine Intervention is Primarily Associated with Gut Microbiota-Metabolism-Inflammatory Signaling Axis
title_short Amelioration of AOM/DSS-Induced Murine Colitis-Associated Cancer by Evodiamine Intervention is Primarily Associated with Gut Microbiota-Metabolism-Inflammatory Signaling Axis
title_sort amelioration of aom/dss-induced murine colitis-associated cancer by evodiamine intervention is primarily associated with gut microbiota-metabolism-inflammatory signaling axis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740177/
https://www.ncbi.nlm.nih.gov/pubmed/35002731
http://dx.doi.org/10.3389/fphar.2021.797605
work_keys_str_mv AT wangmengxia ameliorationofaomdssinducedmurinecolitisassociatedcancerbyevodiamineinterventionisprimarilyassociatedwithgutmicrobiotametabolisminflammatorysignalingaxis
AT zhoubiqiang ameliorationofaomdssinducedmurinecolitisassociatedcancerbyevodiamineinterventionisprimarilyassociatedwithgutmicrobiotametabolisminflammatorysignalingaxis
AT congweihong ameliorationofaomdssinducedmurinecolitisassociatedcancerbyevodiamineinterventionisprimarilyassociatedwithgutmicrobiotametabolisminflammatorysignalingaxis
AT zhangmiao ameliorationofaomdssinducedmurinecolitisassociatedcancerbyevodiamineinterventionisprimarilyassociatedwithgutmicrobiotametabolisminflammatorysignalingaxis
AT liziwen ameliorationofaomdssinducedmurinecolitisassociatedcancerbyevodiamineinterventionisprimarilyassociatedwithgutmicrobiotametabolisminflammatorysignalingaxis
AT liyan ameliorationofaomdssinducedmurinecolitisassociatedcancerbyevodiamineinterventionisprimarilyassociatedwithgutmicrobiotametabolisminflammatorysignalingaxis
AT liangshaoyu ameliorationofaomdssinducedmurinecolitisassociatedcancerbyevodiamineinterventionisprimarilyassociatedwithgutmicrobiotametabolisminflammatorysignalingaxis
AT chenkeji ameliorationofaomdssinducedmurinecolitisassociatedcancerbyevodiamineinterventionisprimarilyassociatedwithgutmicrobiotametabolisminflammatorysignalingaxis
AT yangdepo ameliorationofaomdssinducedmurinecolitisassociatedcancerbyevodiamineinterventionisprimarilyassociatedwithgutmicrobiotametabolisminflammatorysignalingaxis
AT wuzhengzhi ameliorationofaomdssinducedmurinecolitisassociatedcancerbyevodiamineinterventionisprimarilyassociatedwithgutmicrobiotametabolisminflammatorysignalingaxis